. Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease. Neurosci Lett. 2004 Sep 2;367(2):194-6. PubMed.

AlzBiomarker Database

Meta-Analysis

Curated Study Data

Biomarker
(Source)
Cohort
(N)
Measurement
Mean ± SD
Method;
Assay Name;
Manufacturer
Diagnostic
Criteria
Aβ42
(CSF)
AD
(20)
460 ± 26†
pg/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
Aβ42
(CSF)
CTRL-
CNC
(20)
807 ± 57†
pg/mL
ELISA;
Innotest;
Innogenetics
tau-p181
(CSF)
AD
(20)
104 ± 5.5†
pg/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
tau-p181
(CSF)
CTRL-
CNC
(20)
49 ± 3.3†
pg/mL
ELISA;
Innotest;
Innogenetics
tau-total
(CSF)
AD
(20)
1000 ± 71†
pg/mL
ELISA;
Innotest;
Innogenetics
McKhann et al., 1984
tau-total
(CSF)
CTRL-
CNC
(20)
315 ± 27†
pg/mL
ELISA;
Innotest;
Innogenetics

† Mean ± SEM

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.